167 related articles for article (PubMed ID: 2575462)
1. Bioisosteric transformation of H1-antihistaminic benzimidazole derivatives.
Iemura R; Hori M; Saito T; Ohtaka H
Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2723-6. PubMed ID: 2575462
[TBL] [Abstract][Full Text] [Related]
2. Syntheses of the metabolites of 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-1H benzimidazole difumarate (KG-2413) and related compounds.
Iemura R; Hori M; Ohtaka H
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):962-6. PubMed ID: 2569942
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of a new series of benzimidazoles as H1-antihistaminic agents.
Cuberes MR; Contijoch M; Calvet C; Alegre J; Quintana JR; Frigola J
Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1287-92. PubMed ID: 9301027
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of benzimidazole derivatives with potential antihistaminic activity.
Rida SM; el-Dine SA; Labouta IM
Pharmazie; 1977 Oct; 32(10):577-9. PubMed ID: 24226
[No Abstract] [Full Text] [Related]
5. Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents.
Iemura R; Kawashima T; Fukuda T; Ito K; Tsukamoto G
J Med Chem; 1986 Jul; 29(7):1178-83. PubMed ID: 2879912
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationships of H1-antihistaminic benzimidazole derivatives.
Iemura R; Ohtaka H
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):967-72. PubMed ID: 2569943
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new 2-substituted-[1,3,4]-oxadiazino-[6,5-b]-indoles with H1-antihistaminic, antimuscarinic and antimicrobial activity [corrected].
Ajitha M; Rajnarayana K; Sarangapani M
Pharmazie; 2002 Dec; 57(12):796-9. PubMed ID: 12561237
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis of hexahydro-1,4-diazepine derivatives with potential pharmacological effects. IV. Synthesis and studies on the antihistaminic activity of hexahydro-1,4-diazepine derivatives containing ether groups].
Guryn R; Kotełko A; Majchrzak M; Szadowska A; Wejman I
Acta Pol Pharm; 1980; 37(1):53-8. PubMed ID: 6104893
[No Abstract] [Full Text] [Related]
9. 4-(Indolyl-3)-1-(benzimidazolonylalkyl)-piperidines, a novel group of potential antiallergy compounds.
Freter K; Fuchs V; Barsumian E; Oliver JT
Arzneimittelforschung; 1985; 35(1A):272-6. PubMed ID: 2580540
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological activity of benzo[b]thiophene-3-carboxylic acid derivatives.
Shafiee A; Hedayati MA; Salimi MM; Faghihi SM
J Pharm Sci; 1983 Feb; 72(2):198-202. PubMed ID: 6131995
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 3-[2-(2,3-dihydro-5-phenyl-4-substituted-3H-1,2,4- triazole-3-thione-2-yl)-acetylamino]-2-methyl-4(3H)-quinazolinones and their pharmacological activities.
Büyüktimkin S; Büyüktimkin N; Ozdemir O; Rollas S
Arch Pharm (Weinheim); 1989 Jan; 322(1):49-51. PubMed ID: 2567155
[TBL] [Abstract][Full Text] [Related]
12. [4-[Benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds with selective antagonistic activity against H1-histamine receptors].
Mossini F; Maggiali C; Morini G; Impicciatore M; Morini G; Molina E
Farmaco Sci; 1984 Mar; 39(3):189-99. PubMed ID: 6143687
[TBL] [Abstract][Full Text] [Related]
13. [Histamine analogs. 28. 2-(Aryloxyalkyl)- and 3(aminoalkyl)-histamines].
Steffens R; Schunack W
Arch Pharm (Weinheim); 1987 Feb; 320(2):135-40. PubMed ID: 2883957
[No Abstract] [Full Text] [Related]
14. The synthesis of benzimidazole derivatives as potential antihistaminic compounds.
Deshpande SM; Nain K
Bull Chem Soc Jpn; 1967 Apr; 40(4):988-9. PubMed ID: 4383687
[No Abstract] [Full Text] [Related]
15. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.
Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
Drugs R D; 2005; 6(6):371-84. PubMed ID: 16274260
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators.
Fukuda T; Morimoto Y; Iemura R; Kawashima T; Tsukamoto G; Ito K
Arzneimittelforschung; 1984; 34(7):801-5. PubMed ID: 6149754
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antihistaminic (H1)activity of some condensed 2-(substituted)arylaminoethylpyrimidin-4(3H)-ones.
Shishoo CJ; Shirsath VS; Rathod IS; Patil MJ; Bhargava SS
Arzneimittelforschung; 2001; 51(3):221-31. PubMed ID: 11304938
[TBL] [Abstract][Full Text] [Related]
18. Amide derivatives with H1-antihistaminic effect.
Saturnino C; Saturnino P; De Martino G; Lancelot JC; Perrine D; Boureau R; Robba M
Pharm Acta Helv; 1998 Jan; 72(5):279-83. PubMed ID: 9540460
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and H1-antihistaminic activity of beta-alkoxyethyl and beta-(N,N-dialkylamino)ethyl-(3-aryl-3,4-dihydro-4-oxoquinazolin- 2-yl)m ethyl ethers.
Rao AR; Reddy VM
Pharmazie; 1992 Oct; 47(10):794-6. PubMed ID: 1362273
[No Abstract] [Full Text] [Related]
20. Design, synthesis and antihistaminic (H(1)) activity of some condensed 3-aminopyrimidin-4(3H)-ones.
Shishoo CJ; Shirsath VS; Rathod IS; Yande VD
Eur J Med Chem; 2000 Mar; 35(3):351-8. PubMed ID: 10785561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
